Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been scheduled to receive a treatment called 177Lu-PSMA-617 for prostate cancer that has spread and is no longer responding to hormone therapy
- People who have been assessed as clinically stable by their nuclear medicine doctors
- People who are male
- People who are 18 years of age or older
- People who are willing and able to give their informed consent to participate
Who may not be able to join:
- People who are unable to lie flat on a scanning machine for long enough to complete the required imaging procedures
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Response and toxicity following 177Lu-RLT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.